13F

NKTR NEKTAR THERAPEUTICS

2026Q1 · CUSIP 640268306 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
207
Δ holders QoQ
+32
Breadth percentile
Top 9%
Whale holders
93
Δ whales
+18
Inst. holding value
$1.9B
New positions
67
Closed positions
35
Price momentum (1Q)
-7.3%
Put / Call
5/7

Breadth history (34 quarters)

2025Q3: Δ+40 · h=145 2025Q4: Δ+30 · h=175 2026Q1: Δ+32 · h=207 2025Q3: holders=145 2025Q4: holders=175 2026Q1: holders=207 -40 -20 +0 +20 +40 130174218 25Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 9%
2025Q4 Top 17% -7.3%
2025Q3 Top 6% +24.0% +16.6%

Options Sentiment

Put holders
5
QoQ: -1
Call holders
7
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-7.93
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
-36.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $22M 2022-09-30: $24M 2022-12-31: $22M 2023-03-31: $22M 2023-06-30: $20M 2023-09-30: $24M 2023-12-31: $24M 2024-03-31: $22M 2024-06-30: $23M 2024-09-30: $24M 2024-12-31: $29M 2025-03-31: $10M 2025-06-30: $11M 2025-09-30: $12M 2025-12-31: $22M 2026-03-31: $11M 2024-06-30: EPS -3.76 2024-09-30: EPS -2.66 2024-12-31: EPS -2.07 2025-03-31: EPS -3.62 2025-06-30: EPS -2.95 2025-09-30: EPS -1.87 2025-12-31: EPS -1.29 2026-03-31: EPS -1.82 0M 15M 29M $M -4.14 -2.07 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)